Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Hexarelin Mechanism of Action Detailed: Receptor Comparison

GHSR-1a (pituitary) Anterior pituitary somatotrophs 0.4–0.7 nM Calcium mobilisation → GH exocytosis GH-dependent Drives acute GH pulse release within 15–30 minutes GHSR-1a (cardiac) Cardiomyocytes, vascular endothelium 0.5–0.9 nM PI3K/Akt activation → anti-apo

This comparison does not assign a generated winner or score.

  • GHSR-1a (pituitary)
  • Anterior pituitary somatotrophs
  • 0.4–0.7 nM
  • Calcium mobilisation → GH exocytosis
  • GH-dependent
  • Drives acute GH pulse release within 15–30 minutes
  • GHSR-1a (cardiac)
  • Cardiomyocytes, vascular endothelium
  • 0.5–0.9 nM
  • PI3K/Akt activation → anti-apoptotic signalling
  • GH-independent
  • Cardioprotection during ischemia-reperfusion injury
  • GHSR-1a (hepatic)
  • Hepatocytes, Kupffer cells
  • 0.6–1.1 nM
  • AMPK activation → lipid oxidation
  • Reduces hepatic steatosis, improves insulin sensitivity
  • CD36 scavenger receptor
  • Cardiomyocytes, macrophages
  • 15–25 nM (lower affinity)
  • Modulates fatty acid uptake, ROS signalling
  • Potential anti-inflammatory effects in cardiac tissue